Psoriasis

MD IQ

Clinical Topics & News

New Topical Treatments for Psoriasis

For the vast majority of psoriasis patients, topical medications still represent the mainstay of treatment. However, new agents can be added to...

Conference Coverage

What’s new with adalimumab? Plenty

WAIKOLOA, HAWAII – New information includes reassuring new long-term, real-world safety data, plus a simple early predictor of PASI 75 response....

Article

Clearance of Psoriasis After Ischemic Stroke

The nervous system is thought to play an important role in the pathophysiology of psoriasis. A case of a patient with psoriasis who experienced...

Article

Safety and Efficacy of Halobetasol Propionate Lotion 0.01% in the Treatment of Moderate to Severe Plaque Psoriasis: A Pooled Analysis of 2 Phase 3 Studies

Potent topical corticosteroids are the mainstay of psoriasis treatment, but safety concerns have limited use to 2 to 4 weeks. This study...

Pages